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eTable 1 Patient-rated activities of daily living and quality of life scores over time by treatment 
 
 Baseline 3 months 9 months 15 months 
PT/OT No therapy PT/OT No therapy PT/OT No therapy PT/OT No therapy 
NEADL 
Total score N=381 N=381 N=294 N=304 N=289 N=303 N=268 N=283 50.5 (12.9) 50.9 (13.3) 49.6 (14.0) 50.3 (14.5) 47.9 (15.2) 48.9 (14.7) 48.5 (14.8) 46.8 (15.5) 
Mobility N=376 N=372 N=338 N=338 N=317 N=324 N=297 N=308 13.9 (4.0) 13.8 (4.2) 13.6 (4.2) 13.6 (4.4) 13.1 (4.5) 13.4 (4.3) 13.0 (4.4) 12.8 (4.6) 
Kitchen activities N=379 N=373 N=337 N=337 N=322 N=327 N=307 N=318 13.0 (2.7) 13.0 (2.9) 13·0 (3.0) 12.9 (3.2) 12.7 (3.2) 12.6 (3.4) 12.7 (3.0) 12.2 (3.7) 
Domestic tasks N=374 N=370 N=330 N=332 N=313 N=322 N=297 N=310 10.9 (4.2) 11.1 (4.3) 10.4 (4.5) 10.8 (4.4) 10.3 (4.7) 10.4 (4.6) 10.3 (4.5) 9.9 (4.5) 
Leisure activities N=376 N=365 N=318 N=329 N=304 N=319 N=294 N=305 12.9 (4.1) 13.0 (4.0) 13.0 (4.1) 13.1 (4.0) 12.3 (4.4) 12.6 (4.2) 12.3 (4.4) 12.1 (4.5) 
PDQ-39 
 N=380 N=377 N=349 N=351 N=326 N=331 N=311 N=323 
Mobility 32.7 (26.1) 31.3 (25.8) 33.2 (27.3) 33.3 (28.0) 36.0 (28.4) 35.2 (27.6) 37.4 (28.4) 38.6 (29.1) 
Activities of daily living 31.3 (23.1) 30.6 (21.8) 32.1 (23.8) 31.5 (23.8) 32.8 (24.1) 34.1 (24.5) 33.3 (24.1) 36.7 (25.7) 
Emotional well-being 23.9 (18.5) 23.0 (18.1) 25.9 (19.8) 25.5 (20.3) 26.0 (21.0) 28.3 (21.0) 27.1 (21.2) 29.8 (22.3) 
Stigma 18.3 (22.9) 17.1 (21.0) 19.8 (23.1) 17.6 (21.3) 20.3 (23.4) 20.1 (21.6) 20.5 (24.2) 21.4 (23.4) 
Social support 6.6 (14.0) 5.7 (11.0) 10.3 (17.4) 9.3 (15.1) 9.8 (17.7) 11.2 (16.8) 10.1 (17.7) 11.7 (16.8) 
Cognition 26.6 (20.1) 27.3 (21.1) 28.8 (20.6) 29.6 (21.6) 29.1 (20.5) 31.7 (21.3) 30.1 (21.9) 32.9 (21.9) 
Communication 16.5 (18.2) 18.5 (19.8) 20.8 (20.1) 21.8 (21.1) 20.6 (20.2) 23.5 (22.8) 22.0 (21.9) 24.2 (21.9) 
Bodily discomfort 34.8 (23.4) 35.9 (24.0) 36.5 (24.4) 38.6 (24.1) 36.7 (23.7) 38.1 (24.9) 36.9 (24.4) 41.6 (24.5) 
Summary index 23.8 (14.5) 23.7 (14.4) 25.9 (16.5) 25.9 (16.5) 26.4 (16.5) 27.8 (17.0) 27.2 (17.4) 29.6 (17.0) 
EQ-5D 
Quotient score N=378 N=374 N=345 N=345 N=321 N=331 N=307 N=319 0.64 (0.27) 0.66 (0.25) 0.65 (0.25) 0.63 (0.26) 0.63 (0.26) 0.60 (0.27) 0.61 (0.27) 0.58 (0.27) 
Visual analogue score N=376 N=376 N=346 N=347 N=322 N=328 N=309 N=314 68.5 (17.5) 68.6 (17.0) 67.4 (18.2) 66.8 (17.8) 65.8 (18.3) 64.5 (18.6) 64.7 (19.2) 63.0 (18.9) 
Data is Mean (SD). NEADL total score: ranges from 0 to 66 where higher scores are better. PDQ-39: ranges from 0 to 100 where lower scores are better. EQ-5D quotient: ranges from -
0·59 to 1 where higher scores are better. EQ-5D VAS: ranges from 0 to 100 where higher scores are better. 
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eTable 2 Mean change from baseline in patient-rated activities of daily living and quality of life scores by treatment 
 
 Baseline vs. 3 months Mean difference  
(95% CI)† 
Baseline vs. 9 months Mean difference  
(95% CI)† 
Baseline vs. 15 months Mean 
difference  








Total score N=294 N=304 0.5 (-0.7 to 1.7) p=0.4 
N=289 N=303 0.6 (-0.7 to 1.9) 
p=0.4 
N=268 N=283 -1.2 (-2.8 to 0.3) 
p=0.1 -1.5 (7.8) -1.0 (7.4) -3.6 (8.1) -3.0 (8.4) -3.8 (8.6) -5.0 (9.8) 
Mobility N=334 N=330 0.1 (-0.3 to 0.5) p=0.6 
N=314 N=315 0.3 (-0.1 to 0.7) 
p=0.1 
N=294 N=301 -0.2 (-0.6 to 0.3) 
p=0.4 -0.4 (2.6) -0.2 (2.4) -1.0 (2.6) -0.7 (2.7) -1.1 (2.7) -1.3 (3.1) 
Kitchen  
activities 
N=335 N=329 0.005 (-0.3 to 0.3) 
p=1.0 
N=321 N=319 -0.04 (-0.4 to 0.3) 
p=0.8 
N=306 N=312 -0.3 (-0.7 to 
0.05) 
p=0.4 
-0.2 (2.2) -0.2 (1.9) -0.5 (2.5) -0.6 (2.2) -0.6 (2.5) -0.9 (2.5) 
Domestic  
tasks 
N=325 N=323 0.5 (-0.06 to 1.0) 
p=0.08 
N=307 N=314 0.1 (-0.4 to 0.6) 
p=0.7 
N=292 N=302 -0.3 (-0.9 to 0.2) 
p=0.2 -0.8 (3.4) -0.3 (3.2) -1.0 (3.3) -0.8 (3.5) -1.1 (3.6) -1.4 (3.7) 
Leisure  
activities 
N=316 N=318 0.01 (-0.4 to 0.4) 
p=0.9 
N=302 N=307 0.04 (-0.3 to 0.4) 
p=0.8 
N=292 N=291 -0.3 (-0.7 to 0.2) 
p=0.2 -0.2 (2.4) -0.1 (2.4) -0.9 (2.4) -0.8 (2.5) -1.1 (2.7) -1.3 (2.9) 
PDQ-39 
 N=348 N=347  N=325 N=327  N=310 N=319  
Mobility 1.1 (17.1) 2.6 (15.8) -1.5 (-3.9 to 1.0) p=0.2 4.5 (17.5) 5.9 (16.7) 
-1.3 (-4.0 to 1.3) 
p=0.3 6.4 (19.4) 9.3 (20.5) 
-2.9 (-6.0 to 0.2) 
p=0.0 
Activities of  
daily living 1.6 (14.3) 1.0 (16.7) 
0.7 (-1.7 to 3.0) 
p=0.6 3.1 (15.5) 4.1 (16.7) -1.0 (3.5 to 1.5) p=0.4 4.1 (17.1) 7.0 (18.9) 




well-being 2.6 (13.1) 3.0 (16.8) 
-0.5 (-2.7 to 1.8) 
p=0.7 3.5 (15.0) 6.0 (15.3) 
-2.5 (-4.9 to -0.2) 
p=0.03 4.6 (16.1) 7.7 (17.5) 
-3.1 (-5.7 to -
0.5) p=0.02 
Stigma 1.6 (17.7) 0.9 (17.5) 0.7 (-2.0 to 3.3) p=0.6 2.5 (16.1) 3.3 (17.8) 
-0.8 (-3.4 to 1.8) 
p=0.5 2.8 (18.0) 4.5 (18.0) 
-1.6 (-4.5 to 1.2) 
p=0.3 
Social  
support 3.6 (15.6) 3.8 (14.9) 
-0.2 (-2.5 to 2.0) 
p=0.8 3.9 (14.7) 5.6 (15.3) 
-1.8 (-4.1 to 0.5) 
p=0.1 4.3 (14.7) 6.3 (15.8) 
-2.0 (-4.4 to 0.4) 
p=0.09 
Cognition 2.2 (16.5) 2.2 (17.0) -0.05 (-2.5 to 2.4) p=1.0 3.0 (16.7) 4.4 (17.7) 
-1.4 (-4.1 to 1.2) 
p=0.3 4.2 (17.7) 6.0 (18.5) 
-1.8 (-4.7 to 1.0) 
p=0.2 
Communic
ation 4.8 (15.7) 3.0 (17.4) 
1.8 (-0.7 to 4.2) 
p=0.2 5.1 (15.9) 5.0 (17.2) 
0.1 (-2.4 to 2.7) 
p=0.9 6.0 (16.2) 5.9 (17.1) 
0.1 (-2.5 to 2.7) 
p=0.9 
Bodily  
discomfort 2.0 (20.7) 2.8 (21.1) 
-0.8 (-3.9 to 2.3) 
p=0.6 2.2 (20.6) 2.3 (22.1) 
-0.07 (-3.3 to 3.2) 
p=1.0 2.3 (20.9) 5.6 (22.9) 
-3.3 (-6.7 to 0.2) 
p=0.06 
Summary  
index 2.4 (9.5) 2.4 (10.8) 
0.007 (-1.5 to 1.5) 
p=1.0 3.5 (9.7) 4.6 (10.7) -1.1 (-2.7 to 0.5) p=0.2 4.3 (10.6) 6.5 (11.4) 




Quotient N=342 N=338 -0.03 (-0.07 to -0.002) N=321 N=322 -0.03 (-0.07 to 0.008) N=304 N=313 -0.04 (-0.08 to 
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N=341 N=342 -0.2 (-2.6 to 2.2) 
p=0.9 
N=319 N=323 -1.0 (-3.5 to 1.6) 
p=0.4 
N=305 N=309 -1.1 (-3.7 to 1.6) 
p=0.4 -1.8 (17.1) -1.9 (14.3) -3.5 (16.6) -4.5 (16.1) -4.7 (7.3) -5.8 (16.3) 
Data is mean (SD). NEADL total score: a positive change is an improvement in score. PDQ-39: a negative change is an improvement in score. EQ-5D quotient: a positive change is an 
improvement in score. EQ-5D VAS: a positive change is an improvement in score. 
† To aid interpretation, regardless of scale, a positive mean difference favours no therapy group and a negative mean difference favours PT/OT group. 
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eTable 3 Carer-rated quality of life scores over time by treatment 
 
 Baseline 3 months 9 months 15 months 
PT/OT No therapy PT/OT No therapy PT/OT No therapy PT/OT No therapy 
SF-12 
Physical functioning N=171 N=181 N=169 N=181 N=162 N=169 N=156 N=166 70.3 (35.4) 76.0 (30.5) 68.6 (35.8) 70.3 (30.0) 68.5 (35.6) 70.3 (30.9) 65.4 (36.2) 68.2 (32.3) 
Role physical N=173 N=183 N=169 N=185 N=166 N=174 N=157 N=169 75.4 (28.5) 76.7 (26.8) 69.8 (28.8) 71.0 (27.1) 68.5 (35.6) 71.6 (25.4) 64.9 (29.4) 68.8 (25.7) 
Role emotional N=172 N=182 N=170 N=183 N=166 N=174 N=159 N=167 83.6 (23.1) 81.9 (22.9) 80.4 (24.2) 76.4 (24.9) 76.4 (26.1) 75.6 (26.0) 73.9 (26.7) 75.3 (25.2) 
Social functioning N=175 N=186 N=171 N=189 N=167 N=175 N=159 N=172 84.9 (22.9) 83.3 (23.6) 81.0 (24.5) 78.3 (26.9) 77.5 (27.5) 80.0 (26.5) 77.0 (28.3) 75.4 (27.8) 
Mental health N=174 N=183 N=170 N=188 N=165 N=174 N=157 N=169 68.8 (21.1) 68.6 (18.5) 67.6 (20.2) 64.6 (21.9) 65.4 (21.4) 63.4 (21.3) 64.7 (22.5) 61.8 (21.5) 
Vitality N=175 N=184 N=170 N=188 N=165 N=174 N=158 N=171 57.4 (25.6) 61.8 (22.6) 53.8 (25.9) 53.2 (24.5) 53.5 (27.3) 51.4 (25.5) 48.9 (27.1) 51.6 (22.9) 
Bodily pain N=173 N=184 N=170 N=189 N=166 N=174 N=159 N=172 77.7 (29.3) 76.4 (28.7) 74.1 (28.8) 74.2 (28.5) 73.2 (28.3) 72.0 (27.8) 73.3 (29.4) 69.8 (28.5) 
General health N=174 N=186 N=170 N=190 N=167 N=175 N=159 N=172 64.2 (25.3) 65.6 (26.1) 58.9 (26.0) 61.0 (25.3) 57.8 (25.9) 59.7 (26.0) 57.0 (26.0) 58.1 (25.7) 
Physical component score N=166 N=171 N=165 N=174 N=158 N=166 N=152 N=160 47.1 (12.5) 48.2 (11.4) 45.1 (13.3) 46.4 (11.6) 45.4 (12.5) 46.2 (11.2) 44.2 (12.8) 45.4 (11.5) 
Mental component score N=166 N=171 N=165 N=174 N=158 N=166 N=152 N=160 51.1 (10.2) 50.1 (8.9) 49.7 (10.2) 48.0 (10.5) 48.2 (10.8) 47.5 (10.8) 47.5 (11.0) 46.7 (10.6) 
 
Data is Mean (SD). SF-12: ranges from 0 – 100 where higher scores are better. 
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eTable 4 Mean change from baseline in carer-rated quality of life scores by treatment 
 
 Baseline vs. 3 months Mean Difference  
(95% CI)† 
Baseline vs. 9 months Mean Difference  
(95% CI)† 
Baseline vs. 15 months Mean Difference  








N=151 N=156 -5.6 (-11.0 to -0.2) 
p=0.04 
N=141 N=145 -5.3 (-11.2 to 0.6) 
p=0.08 
N=139 N=143 -4.2 (-11.0 to 2.3) 
p=0.2 -0.7 (24.8) -6.3 (23.0) -1.4 (25.0) -6.7 (25.9) -5.8 (26.3) -10.0 (31.0) 
Role Physical N=155 N=163 -0.5 (-5.3 to 4.3) p=0.8 
N=146 N=151 0.6 (-4.9 to 6.1) 
p=0.8 
N=139 N=147 2.5 (-3.3 to 8.3) 
p=0.4 -5.4 (19.6) -5.9 (23.8) -6.1 (22.7) -5.5 (25.6) 11.5 (24.2) -9.0 (25.4) 
Role 
Emotional 
N=155 N=162 -4.4 (-9.0 to 0.2) 
p=0.06 
N=145 N=151 1.0 (-4.2 to 6.1) 
p=0.7 
N=140 N=144 1.9 (-3.3 to 7.1) 
p=0.5 -1.7 (20.0) -6.1 (21.5) -7.6 (20.5) -6.6 (24.1) -10.4 (21.0) -8.6 (23.4) 
Social 
Functioning 
N=157 N=169 -3.8 (-8.9 to 1.3) 
p=0.1 
N=149 N=154 1.1 (-4.9 to 7.1) 
p=0.7 
N=143 N=153 -0.5 (-6.6 to 5.6) 
p=0.9 -2.9 (21.9) -6.7 (24.5) -7.7 (26.0) -6.7 (27.0) -9.6 (27.5) -10.1 (27.3) 
Mental Health N=156 N=167 -4.3 (-8.2 to -0.4) p=0.03 
N=147 N=151 -1.9 (-6.1 to 2.3) 
p=0.4 
N=142 N=149 -2.6 (-7.2 to 2.0) 
p=0.3 -0.2 (16.7) -4.5 (18.9) -3.7 (19.5) -5.6 (17.5) -4.9 (21.1) -7.6 (18.8) 
Vitality N=156 N=167 -4.6 (-9.2 to 0.05) p=0.05 
N=147 N=151 -7.3 (-12.6 to -2.1) 
p=0.007 
N=142 N=150 -2.7 (-8.1 to 2.8) 
p=0.3 -3.5 (21.0) -8.1 (21.1) -4.3 (21.8) -11.6 (24.5) -9.7 (23.8) -12.3 (23.5) 
Bodily Pain N=156 N=168 2.9 (-2.2 to 7.9) p=0.3 
N=146 N=152 -0.3 (-6.0 to 5.4) 
p=0.9 
N=141 N=151 -2.5 (-8.5 to 3.6) 
p=0.4 -4.6 (25.0) -1.8 (21.1) -4.8 (25.6) -5.1 (24.1) -5.1 (25.6) -7.6 (26.8) 
General 
Health 
N=155 N=170 -0.9 (-5.0 to 3.3) 
p=0.7 
N=148 N=154 -0.7 (-5.7 to 4.5) 
p=0.8 
N=143 N=153 -0.08 (-5.3 to 5.2) 





-0.6 (-2.3 to 1.2) 
p=0.5 
N=133 N=135 -1.4 (-3.5 to 0.7) 
p=0.2 
N=132 N=129 -1.0 (-3.3 to 1.3) 





-2.1 (-3.9 to -0.3) 
p=0.02 
N=133 N=135 -0.05 (-2.2 to 2.1) 
p=1.0 
N=132 N=129 0.3 (-2.0 to 2.5) 
p=0.8 -0.5 (7.6) -2.6 (7.9) -2.8 (8.6) -2.8 (9.1) -4.2 (9.9) -4.0 (8.7) 
SF-12: a positive change is an improvement in score. 
† To aid interpretation, regardless of scale, a positive mean difference favours no therapy group and a negative mean difference favours PT/OT group. 
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PT/OT No therapy 























hospital stay or 
prolongation of 
hospitalisation 
3 months Falls 10 17 1 3 4 9 11 2 8 2 
 Injuries using 
equipment 
1 0 0 0 0 1 0 0 0 0 
15 months Falls 43 68 17 34 13 49 69 21 37 14 
 Injuries using 
equipment 
1 0 0 0 0 1 0 0 0 0 
* Following a risk assessment, only therapy-related adverse events and serious adverse events were recorded. These were defined as falls or equipment failure leading to injury requiring 
a hospital, general practitioner (GP), ambulance visit, or death. 
 
  




Figure 1 CONSORT diagram for PD REHAB. Patient recruitment and follow-up 
 
Figure 2 Long-term scores in activities of daily living and quality of life 
 
 
eFigure 1 Subgroup analyses for NEADL total score at 3 months 
 
 
